Prostate Cancer Stereotactic Radiotherapy

NCT02319239 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Prostate Neoplasms
Toxicity Due to Radiotherapy

Interventions

RADIATION: Fractionation
RADIATION: hypofractionated
RADIATION: stereotactic fractionation

Sponsor

Tampere University Hospital